Pharmacokinetics, Safety and Tolerability of Single-dose or Multiple-dose Cefiderocol in Hospitalized Pediatric Patients Three Months to Less Than Eighteen Years Old with Infections Treated with Standard-of-care Antibiotics in the PEDI-CEFI Phase 2 Study.
PEDIATRIC INFECTIOUS DISEASE JOURNAL（2025）
Key words
cefiderocol,multidrug-resistant Gram-negative bacteria,pediatric,pharmacokinetics,safety
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined